Skip to Content

    News

    News

    The Alzheimer's Association is dedicated to promoting awareness of the latest Alzheimer's research, resources and news. Any news release posted here reflects the knowledge, statistics and position of the Alzheimer's Association at that time. Browse and share the articles below, or sign up for our e-newsletter to stay informed on the global fight against Alzheimer's.

    Featured News Items

    Press releases & statements

    Alzheimer’s Association Statement on Topline Results from the CELIA Phase 2 Clinical Trial of Tau-Targeting Therapy Diranersen (BIIB080)

    New CELIA phase 2 clinical trial results for diranersen, a tau-targeting treatment for early-stage Alzheimer’s, mark important progress for the Alzheimer’s community.
    May 14, 2026
    Press releases & statements

    House Subcommittee Acts to Expand Dementia Training for Health Care Providers

    This critical step advances legislation that will improve diagnosis of Alzheimer’s and other dementia and expand access to high-quality, person-centered care.
    May 13, 2026

    Alzheimer’s Association Launches (re)think your brain to Drive Early Action on Brain Health

    Grounded in science, the initiative provides everyday actions that support brain health and may help reduce the risk of dementia.
    May 11, 2026
    Press releases & statements

    Alzheimer’s Disease Drug Development Pipeline is Growing in Size, Number and Variety

    Year-over-year and 10-year data show more drugs that target more aspects of the disease are being tested in more trials, providing a “basis for optimism.”
    May 5, 2026
    Press releases & statements

    Alzheimer’s Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer’s Disease Agitation

    The Alzheimer’s Association welcomes today’s FDA approval of Auvelity® (dextromethorphan-bupropion) for agitation associated with Alzheimer’s disease.
     
    April 30, 2026
    Press releases & statements

    Alzheimer’s Association Brings "Unforgettable" from Stage to Screen

    The film expands the reach of the acclaimed stage play to raise awareness of Alzheimer's, clinical trial participation and health equity.
    April 30, 2026

    Press Resources

    Access a range of media resources to support your reporting, including downloadable fact sheets, infographics, videos, official statements, and background materials about the Alzheimer’s Association and our mission.

    View Press Resources

    Speaker Bios

    Maria C. Carrillo, Ph.D.

    Chief Science Officer and Medical Affairs Lead, Alzheimer’s Association

    See Bio

    Robert Egge

    Chief Public Policy Officer, Alzheimer’s Association and President, Alzheimer's Impact Movement

    See Bio

    Heather M. Snyder, Ph.D.

    Senior Vice President, Medical & Scientific Operations

    See Bio